Table 3.
Factors influencing 25-hydroxyvitamin D levels.
β | SE | P value | |
---|---|---|---|
Intercept | 5.994 | 0.621 | <0.0001 |
Females | −0.332 | 0.052 | <0.0001 |
July | 0.254 | 0.101 | 0.012 |
August | 0.444 | 0.084 | <0.0001 |
September | 0.329 | 0.079 | <0.0001 |
Diabetes mellitus | −0.181 | 0.091 | 0.048 |
ln BMI | −0.900 | 0.361 | 0.013 |
CNI | −0.177 | 0.084 | 0.036 |
Age (years) | 0.0001 | 0.002 | 0.963 |
Proteinuria (g/L) | −0.028 | 0.028 | 0.325 |
ln eGFR | −0.019 | 0.071 | 0.791 |
Oral steroids | 0.015 | 0.066 | 0.821 |
Pulse steroids | −0.096 | 0.086 | 0.264 |
Azathioprine | −0.159 | 0.147 | 0.279 |
Mycophenolates | −0.099 | 0.126 | 0.435 |
mTORI | 0.124 | 0.084 | 0.144 |
Dependent variable: ln 25-hydroxyvitamin D; adjusted R 2 = 0.345.
BMI – body mass index, SE – standard error; eGFR – estimated glomerular filtration rate (CKD-EPI), CNI – calcineurin inhibitors, mTORI – mammalian target of Rapamycin inhibitors.